Therapy of severe chronic congestive heart failure

Effect of nesiritide in patients with acute decompensated heart failure.

The New England journal of medicine·2011

Mode of death in heart failure: findings from the ATLAS trial.

Heart (British Cardiac Society)·2002

Congestive heart failure with preserved systolic function in a statewide sample of community hospitals.

Journal of cardiac failure·2001

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.

Archives of internal medicine·2001

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.

European journal of heart failure·2000

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.

European heart journal·2000

Health Status Relationship to Ischemia and Coronary Artery Disease Severity in the ISCHEMIA Trial.

American heart journal·2026

Guideline-Directed Medical Therapy and Clinical Outcomes in Adults with Fontan Palliation and Systemic Ventricular Systolic Dysfunction.

American heart journal·2026

Comparative effectiveness of influenza vaccination dosing strategies for cardiovascular protection: a systematic review and network meta-analysis of randomised controlled trials.

American heart journal·2026

Mavacamten monotherapy in obstructive hypertrophic cardiomyopathy: an integrated analysis of phase 3 clinical trials.

American heart journal·2026

Cleaner Air for Lower Cardiometabolic Risk: protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes.

American heart journal·2026

Cardiac Allograft Vasculopathy and Secondary Outcomes at 1-year in Heart Transplantation from Circulatory Death Donors.

American heart journal·2026

Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.

Journal of clinical hypertension (Greenwich, Conn.)·2026

Loeffler's Endomyocarditis With Embolic Stroke Secondary to Chronic Eosinophilic Leukemia With Therapy-Related Molecular Features.

JACC. Case reports·2026

Outcomes After Lymphatic Embolization for Protein-Losing Enteropathy in Congenital Heart Disease.

Journal of the American College of Cardiology·2026

Diagnostic Performance of Reticulocyte Hemoglobin Content (CHr) for Iron Deficiency in Chronic Kidney Disease: A Reanalysis of a Published South African Dataset.

International journal of laboratory hematology·2026

Systemic Adverse Effects of Intensive Blood Pressure Treatment After Craniotomy for Tumor Resection.

Neurosurgery·2026

A Review of the Clinical Utility of Tubule-Specific Biomarkers in Sickle Cell Nephropathy.

BioMed research international·2026

Related Experiment Videos

Therapy of severe chronic congestive heart failure

Related Concept Videos

Effect of nesiritide in patients with acute decompensated heart failure.

Mode of death in heart failure: findings from the ATLAS trial.

Congestive heart failure with preserved systolic function in a statewide sample of community hospitals.

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.

Health Status Relationship to Ischemia and Coronary Artery Disease Severity in the ISCHEMIA Trial.

Guideline-Directed Medical Therapy and Clinical Outcomes in Adults with Fontan Palliation and Systemic Ventricular Systolic Dysfunction.

Comparative effectiveness of influenza vaccination dosing strategies for cardiovascular protection: a systematic review and network meta-analysis of randomised controlled trials.

Mavacamten monotherapy in obstructive hypertrophic cardiomyopathy: an integrated analysis of phase 3 clinical trials.

Cleaner Air for Lower Cardiometabolic Risk: protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes.

Cardiac Allograft Vasculopathy and Secondary Outcomes at 1-year in Heart Transplantation from Circulatory Death Donors.

Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.

Loeffler's Endomyocarditis With Embolic Stroke Secondary to Chronic Eosinophilic Leukemia With Therapy-Related Molecular Features.

Outcomes After Lymphatic Embolization for Protein-Losing Enteropathy in Congenital Heart Disease.

Diagnostic Performance of Reticulocyte Hemoglobin Content (CHr) for Iron Deficiency in Chronic Kidney Disease: A Reanalysis of a Published South African Dataset.

Systemic Adverse Effects of Intensive Blood Pressure Treatment After Craniotomy for Tumor Resection.

A Review of the Clinical Utility of Tubule-Specific Biomarkers in Sickle Cell Nephropathy.

Related Experiment Videos

Therapy of severe chronic congestive heart failure

Related Concept Videos

Related Articles